Lekadol Forte

Paracetamol, the active ingredient in Lekadol Forte, is an analgesic, antipyretic presented as an oral tablet for oral use. It treats mild to moderate pain and reduces fever in adults and children when used as directed.

GNH USA supplies Lekadol Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lekadol Forte, a paracetamol‑based analgesic and antipyretic, is employed across several common conditions where pain or fever are present. - Pain: provides relief from headaches, toothaches, musculoskeletal discomfort, and other mild to moderate pain. - Fever: helps lower elevated body temperature associated with infections or inflammatory states. - Cold and flu symptoms: alleviates aches, pains and fever that accompany upper respiratory infections.

Paracetamol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset may be experienced. - Rash: occasional skin irritation or mild rash. - Elevated liver enzymes: transient changes in liver function tests. - Headache: paradoxical headache in some users. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury, especially with overdose. - Stevens‑Johnson syndrome: rare severe skin reaction. - Anaphylaxis: extremely rare allergic reaction with breathing difficulty. - Blood disorders: rare cases of thrombocytopenia or neutropenia. - Renal impairment: uncommon kidney function decline with prolonged high dosing.

When using Lekadol Forte, consider the following safety measures. - Do not exceed the recommended daily dose: avoid cumulative intake above 4 g per day. - Avoid concurrent use with other paracetamol‑containing products: prevents accidental overdose. - Limit alcohol consumption: reduces risk of liver toxicity. - Use with caution in patients with pre‑existing liver disease: monitor hepatic function. - Adjust dose in elderly or frail patients: consider lower dosing or increased monitoring. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Paracetamol may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Other paracetamol‑containing products: risk of cumulative overdose. - Strong CYP450 inducers (e.g., rifampicin, carbamazepine): may lower plasma concentrations. - Alcohol and hepatotoxic drugs (e.g., isoniazid, methotrexate): increase risk of liver injury.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Antiretrovirals (e.g., ritonavir): can alter paracetamol metabolism. - Certain anticonvulsants (e.g., phenytoin): may affect drug clearance.